Isaac Manke - 31 Dec 2025 Form 4 Insider Report for OnKure Therapeutics, Inc. (OKUR)

Reporting relationship: Director
Issuer ticker: OKUR
Reported as of: 31 Dec 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Jan 2026, 16:10:23 UTC
Prior SEC filing: 27 Oct 2025
Next SEC filing: 18 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Rogan Nunn, by power of attorney

Key filing fact

Isaac Manke filed Form 4 for OnKure Therapeutics, Inc. (OKUR) on 02 Jan 2026.

Key facts

This page summarizes Isaac Manke's Form 4 filing for OnKure Therapeutics, Inc. (OKUR).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 02 Jan 2026, 16:10.

Change

Previous filing in this sequence was filed on 27 Oct 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001622769 Primary reporting owner

Manke Isaac

Relationship: Director
Address: C/O ONKURE THERAPEUTICS, INC., 6707 WINCHESTER CIRCLE, SUITE 400, BOULDER
Signature: /s/ Rogan Nunn, by power of attorney
Signature date: 02 Jan 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OKUR transaction

Class A Common Stock

Award

Transaction value: $0
Shares: +5,258
Change %: +34%
Price: $0.000000
Shares after: 20,583
Date: 31 Dec 2025
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These securities are fully vested restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Class A Common Stock. The RSUs were granted to the Reporting Person in lieu of a quarterly cash retainer, at the election of the Reporting Person, under the Issuer's Outside Director Compensation Policy.